Obesity Prevalence and Treatment Paradigm Shift: With over one billion people globally living with obesity and only a fraction receiving pharmacotherapy, the addressable market dwarfs diabetes alone [1]
APPLICATION : One capsule per day
Tissue Repair Support : Preclinical studies suggest involvement in cellular signaling related to tissue healing, which connects to recovery from muscle, tendon, and ligament injuries, reflecting key benefits of BPC-157 in experimental recovery models
Medical-Grade GHK-Cu Therapy Administered via targeted injection or protocol-specific delivery for optimal cellular signaling
Users should consult a healthcare professional before starting semaglutide and discuss potential drug interactions or allergies they might have so that the best decisions are made when it comes to their health
All experiments were approved by the Ethics Committee of the Plastic Surgery Hospital (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
